51 reports

Major players in the antifungals market are Pfizer, Novartis, Merck & Co., Bayer Healthcare and Abbott Laboratories, Sanofi-Aventis, Kramer Laboratories, Glaxosmithkline Gilead, Enzon Pharmaceuticals Inc. and Basilea Pharmaceutica AG. The global antifungals market is expected to grow from $26.76 billion in 2021 to $30.94 billion in...

  • Antifungal
  • World
  • Middle East
  • APAC

Report Scope: The aim of this report is to initially conduct a review of the antifungal drugs currently available; explore the issues facing the use of antifungal drugs; and review some of the latest developments of new and innovative antifungal drugs, their technologies, and their intended clinical applications. The key...

  • Antifungal
  • World

Major players in the antifungals market are Pfizer, Novartis, Merck & Co., Bayer Healthcare and Abbott Laboratories. The global antifungals market is expected to grow from $9.98 billion in 2020 to $10.29 billion in 2021 at a compound annual growth rate (CAGR) of 3.1%. The growth is mainly due to the companies rearranging their operations...

  • Antifungal
  • World

Abstract: - Global Antifungal Drugs Market to Reach $17.5 Billion by 2027 - Amid the COVID-19 crisis, the global market for Antifungal Drugs estimated at US$14.9 Billion in the year 2020, is projected to reach a revised size of US$17.5 Billion by 2027, growing at a CAGR of 2.3% over the analysis period 2020-2027. Azoles,...

  • Antifungal
  • World
  • China
  • United States

Abstract: - Global Antimicrobial Ingredients Market to Reach 94.1 Thousand Tons by 2027 - Amid the COVID-19 crisis, the global market for Antimicrobial Ingredients estimated at 78.2 Thousand Tons in the year 2020, is projected to reach a revised size of 94.1 Thousand Tons by 2027, growing at a CAGR of 2.7% over the...

  • Antifungal
  • Antiviral
  • Antiseptics
  • Anti-Infective
  • World
  • China
  • United States

The global antifungal drugs market exhibited moderate growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of around 4% during 2021-2026. Antifungal drugs, or antimycotic drugs, refer to the pharmaceutical medicines used for the treatment of fungal infections on skin, hair...

  • Antifungal
  • World

Global Antifungal Drugs Market 2020-2024 The analyst has been monitoring the antifungal drugs market and it is poised to grow by USD 2.50 bn during 2020-2024 progressing at a CAGR of 4% during the forecast period. Our reports on antifungal drugs market provides a holistic analysis, market size and forecast, trends, growth...

  • Antifungal
  • World

Tinea Pedis (Athlete Foot) (Infectious Disease) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Tinea Pedis (Athlete Foot) – Drugs In Development, 2021, provides an overview of the Tinea Pedis (Athlete Foot) (Infectious Disease) pipeline landscape. Athlete’s...

  • Antifungal
  • Infectious Disease
  • Drug Development
  • World
  • United States

The global Antifungal Drugs market is expected to reach US$ 13,524.2 Mn in 2027 from US$ 10,182.3 Mn in 2018. The market is estimated to grow with a CAGR of 3.2% from 2019-2027. The market is driven by the factors such as, rising incidences for the fungal infection of the skin, nails and hair, increasing incidences of cancers, HIV, and...

  • Antifungal
  • APAC
  • World
  • Cancer Incidence
  • Health Expenditure

The global onychomycosis treatment market reached a value of US$ 2.94 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 4.12 Billion by 2027, exhibiting a CAGR of 5.50% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect...

  • Antifungal
  • Infectious Disease
  • World

“14-Alpha Demethylase Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in 14-Alpha Demethylase Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type,...

  • Therapy
  • Antifungal
  • Clinical Development
  • World
  • United States

Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Antifungal Drugs Market. The report analyses the Antifungal Drugs Market By Drug Type (Azoles, Echinocandins,...

  • Antifungal
  • World
  • APAC
  • Europe
  • North America
  • China
  • Canada
  • Japan
  • Germany
  • Health Expenditure
  • HIV AIDS Prevalence

Antifungal Drugs Market Size, Share & Trends Analysis Report By Drug Class (Azoles, Echinocandins, Polyenes, Allyamines), By Indication (Dermatophytosis, Aspergillosis, Candidiasis), and Segment Forecasts, 2018 - 2025 The global antifungal drugs market size is expected to reach USD 12.7 billion by 2025, according to...

  • Antifungal
  • World
  • HIV AIDS Prevalence

About this market Advances in diagnosis of antifungal resistant pathogens to drive market growth. Although the currently available antifungal drugs are killing various species of candidiasis, some fungi can develop the ability to defend these drugs. For instance, Candida auris, an emerging antifungal¬resistant yeast, is...

  • Infectious Disease
  • Antifungal
  • World

When the current global crisis has abated, efforts must turn to future preventative measures Nanocoatings can demonstrate up to 99.9998% effectiveness against bacteria, formaldehyde, mold and viruses and are up to 1000 times more efficient than previous technologies available on the market They can work on multiple levels at the same time:...

  • Antiviral
  • Antiseptics
  • Antifungal
  • World

This study covers the world outlook for antifungal pharmaceuticals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Antifungal
  • Pharmaceutical
  • World
  • Gross Domestic Product
  • Disposable Income

This study covers the world outlook for at-home vaginal antifungal treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Antifungal
  • World
  • Gross Domestic Product
  • Disposable Income

This study covers the world outlook for topical antifungal medications across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Antifungal
  • World
  • Gross Domestic Product
  • Disposable Income

KEY FINDINGS The global antifungal agents market is chiefly being propelled by factors like poor hygiene habits, supportive policies and programs by government and the development of drug resistance. By the end of the forecast period of 2018-2026, the market is likely to register a CAGR of 3.72%. MARKET INSIGHTS The...

  • Antifungal
  • World
  • APAC

KEY FINDINGS Asia Pacific antifungal agent market is being driven by factors like poor hygiene in the region, the development of new antifungal drugs and supportive government programs. By the end of the forecast period of 2018-2026, the market is likely to register a CAGR of 5.39%. MARKET INSIGHTS The...

  • Antifungal
  • APAC

KEY FINDINGS Huge investments made for drug productions, along with the government initiatives related to fungal infections and their treatment are driving growth in the North America antifungal agents market. Over the forecast years of 2018-2026, the market is likely to showcase a CAGR of 2.80%. MARKET INSIGHTS Canada...

  • Antifungal
  • North America
  • World
  • United States

KEY FINDINGS The spectrum of fungal infections ranges from the localized skin and soft tissue infections to fungemia, with disseminated disease to almost any organ system.In recent years, the prevalence of such infections has multiplied considerably, thus increasing the market demand for antifungal agents. Over the...

  • Antifungal
  • Europe

Summary Pulmatrix Inc (Pulmatrix), formerly Ruthigen Inc is a clinical stage biopharmaceutical company that develops inhaled therapeutic products intended for prevention and treatment of respiratory diseases and infections.The company develops its pipeline product using its proprietary inhaled small particles easily respirable...

  • Therapy
  • Pharmaceutical
  • Cystic Fibrosis
  • Antifungal
  • Healthcare
  • North America
  • Manufacturing Output
  • Drug Approval

This study covers the latent demand outlook for antifungal pharmaceuticals across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the percent share the city is...

  • Pharmaceutical
  • Antifungal
  • United States
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for antifungal pharmaceuticals across the states, union territories, and cities of India. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 4,900 cities in India. For each city in question, the percent share the city is of...

  • Pharmaceutical
  • Antifungal
  • India
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for antifungal pharmaceuticals across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter...

  • Pharmaceutical
  • Antifungal
  • China
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for topical antifungal medications across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the percent share the city...

  • Antifungal
  • United States
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for at-home vaginal antifungal treatments across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the percent share...

  • Antifungal
  • United States
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for topical antifungal medications across the states, union territories, and cities of India. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 4,900 cities in India. For each city in question, the percent share the city is...

  • Antifungal
  • India
  • United States
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for at-home vaginal antifungal treatments across the states, union territories, and cities of India. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 4,900 cities in India. For each city in question, the percent share the...

  • Antifungal
  • India
  • United States
  • Disposable Income
  • Purchasing Power Parity